Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Opus Genetics Inc (IRD)

Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Opus Genetics Inc 8 Davis Drive Suite 220 Durham NC 27713 USA

https://opusgtx.com Employees: 18 P: 984-884-6030

Sector:

Medical

Description:

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 137,928
Enterprise Value, $K 126,448
Shares Outstanding, K 68,964
Annual Sales, $ 10,990 K
Annual Net Income, $ -57,530 K
Last Quarter Sales, $ 3,080 K
Last Quarter Net Income, $ -17,450 K
EBIT, $ -65,180 K
EBITDA, $ -65,170 K
60-Month Beta 0.42
% of Insider Shareholders 6.60%
% of Institutional Shareholders 14.97%
Float, K 64,412
% Float 93.40%
Short Interest 582
Short Float 0.84%
Short Volume Ratio 0.37

Growth:

1-Year Return 102.61%
3-Year Return -20.32%
5-Year Return -63.57%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 11/12/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -1.83
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 58.62%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/06/20

IRD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -697.94%
Return-on-Assets % -153.88%
Profit Margin % -523.48%
Debt/Equity 0.18
Price/Sales 12.42
Price/Cash Flow N/A
Price/Book 19.88
Book Value/Share 0.10
Interest Coverage -2.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar